RCSI cancer researchers, in collaboration with industry and our clinical sites, are discovering new ways to improve outcomes for cancer patients by optimising prevention, diagnosis and therapy.
We aim to determine the causes of a wide variety of cancer types – with a particular focus on breast, neuroblastoma, brain, ovarian and colorectal cancer – at the molecular level in order to identify targets for the development of new therapies.Read our impact stories
We bring together clinicians, biologists, epidemiologists, statisticians and chemists to facilitate cancer research with the goal of achieving international excellence and improving patient outcomes. In this RCSI MyHealth lecture, three leading cancer experts explore the causes of cancer, risk factors, prevention, genetics, symptoms and treatment.
"RCSI carries out research that brings maximum benefit to cancer patients and ensures that Ireland is at the forefront of excellent patient care now and in the future."
"My research goal is to develop effective strategies to help patients with leptomeningeal disease (when cancer cells migrate from your breast, lung, or other parts of the body to the cerebrospinal fluid) by identifying effective treatments."
“By uncovering new vulnerabilities in DNA pathways in brain metastasis, our research opens up the possibility of novel treatment strategies for patients who previously had limited targeted therapy options.”
RCSI plays a leading role in a number of large collaborative cancer research programmes and clinical trials, involving partners from industry, academia and clinical organisations.
An innovative collaboration between RCSI, Beaumont Hospital and St Luke’s Radiation Oncology Network.
A consortium of Irish universities, research charities and international companies aiming to develop new diagnostics and therapeutics for personalised cancer treatments.